Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 90,545 | 91,592 | 94,396 | 74,877 | 117,553 |
| Gross Profit | 90,545 | 91,592 | 94,396 | 74,877 | 117,553 |
| Operating Expenses | 59,054 | 65,956 | 69,419 | 63,857 | 79,964 |
| Operating Income | 31,491 | 25,636 | 24,977 | 11,020 | 37,589 |
| Interest Expense | 8,914 | 9,419 | 7,470 | 7,231 | 8,423 |
| Other Income | 1,418 | 1,152 | 1,369 | 1,169 | 1,194 |
| Pre-tax Income | 23,995 | 17,369 | 18,876 | 4,958 | 30,360 |
| Income Tax | 21,739 | 13,723 | 19,736 | 9,120 | 32,105 |
| Net Income Continuous | 2,256 | 3,646 | -860 | -4,162 | -1,745 |
| Minority Interests | N/A | N/A | N/A | N/A | -658 |
| Net Income | $2,256 | $3,646 | $-860 | $-4,162 | $-1,087 |
| EPS Basic Total Ops | 0.03 | 0.02 | -0.01 | -0.03 | -0.01 |
| EPS Basic Continuous Ops | 0.01 | 0.02 | -0.01 | -0.03 | -0.01 |
| EPS Diluted Total Ops | 0.03 | 0.02 | -0.01 | -0.03 | 0.05 |
| EPS Diluted Continuous Ops | 0.01 | 0.02 | -0.01 | -0.03 | 0.06 |
| EPS Diluted Before Non-Recurring Items | 0.02 | 0.02 | 0.00 | N/A | N/A |
| EBITDA(a) | $31,976 | $26,143 | $25,483 | $11,533 | $38,101 |